JP2009508476A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009508476A5 JP2009508476A5 JP2008529350A JP2008529350A JP2009508476A5 JP 2009508476 A5 JP2009508476 A5 JP 2009508476A5 JP 2008529350 A JP2008529350 A JP 2008529350A JP 2008529350 A JP2008529350 A JP 2008529350A JP 2009508476 A5 JP2009508476 A5 JP 2009508476A5
- Authority
- JP
- Japan
- Prior art keywords
- cell line
- antibody
- polypeptide
- produced
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71305505P | 2005-08-31 | 2005-08-31 | |
| US71285805P | 2005-08-31 | 2005-08-31 | |
| PCT/US2006/034382 WO2007028106A2 (en) | 2005-08-31 | 2006-08-31 | Host cell lines for production of antibody constant region with enhanced effector function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009508476A JP2009508476A (ja) | 2009-03-05 |
| JP2009508476A5 true JP2009508476A5 (https=) | 2009-09-24 |
Family
ID=37809622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008529350A Pending JP2009508476A (ja) | 2005-08-31 | 2006-08-31 | 高められたエフェクター機能をもつ抗体定常領域の製造用の宿主細胞株 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20090214528A1 (https=) |
| EP (1) | EP1937313A4 (https=) |
| JP (1) | JP2009508476A (https=) |
| KR (1) | KR20080048505A (https=) |
| AU (1) | AU2006287224A1 (https=) |
| BR (1) | BRPI0616600A2 (https=) |
| CA (1) | CA2621236A1 (https=) |
| MX (1) | MX2008003054A (https=) |
| WO (1) | WO2007028106A2 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2704600C (en) | 1999-04-09 | 2016-10-25 | Kyowa Kirin Co., Ltd. | A method for producing antibodies with increased adcc activity |
| FR2807767B1 (fr) * | 2000-04-12 | 2005-01-14 | Lab Francais Du Fractionnement | Anticorps monoclonaux anti-d |
| US6946292B2 (en) | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
| SG176088A1 (en) * | 2009-05-29 | 2011-12-29 | Glaxosmithkline Llc | Methods of administration of thrombopoietin agonist compounds |
| WO2011073235A1 (en) * | 2009-12-18 | 2011-06-23 | Csl Ltd. | Method of purifying polypeptides |
| GB201003701D0 (en) * | 2010-03-05 | 2010-04-21 | Cilian Ag | System for the expression of a protein |
| EP2791170A1 (en) | 2011-12-16 | 2014-10-22 | Synthon Biopharmaceuticals B.V. | Compounds and methods for treating inflammatory diseases |
| IL292159B1 (en) | 2012-12-05 | 2026-04-01 | Alnylam Pharmaceuticals Inc | PCSK9 iRNA compositions and methods of using them |
| US8956830B2 (en) | 2013-03-14 | 2015-02-17 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| US9677105B2 (en) | 2013-03-14 | 2017-06-13 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| US9217168B2 (en) | 2013-03-14 | 2015-12-22 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| JP7093612B2 (ja) * | 2014-05-27 | 2022-06-30 | アカデミア シニカ | Ｂａｃｔｅｒｏｉｄｅｓ由来のフコシダーゼおよびそれを使用する方法 |
| CN108348541A (zh) * | 2015-08-25 | 2018-07-31 | 阿尔尼拉姆医药品有限公司 | 用于治疗前蛋白转化酶枯草杆菌蛋白酶kexin(pcsk9)基因相关障碍的方法和组合物 |
| US10465003B2 (en) * | 2016-02-05 | 2019-11-05 | Janssen Biotech, Inc. | Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes |
| WO2018140121A1 (en) * | 2017-01-30 | 2018-08-02 | Janssen Biotech, Inc. | Anti-tnf antibodies, compositions, and methods for the treatment of active psoriatic arthritis |
| MX2019009377A (es) * | 2017-02-07 | 2019-12-11 | Janssen Biotech Inc | Anticuerpos anti-tnf, composiciones y metodos para el tratamiento de la espondilitis anquilosante activa. |
| KR102323342B1 (ko) | 2019-04-26 | 2021-11-08 | 주식회사 와이바이오로직스 | IL-17A 및 TNF-α에 특이적으로 결합하는 이중표적 항체 |
| TWI875757B (zh) * | 2019-05-08 | 2025-03-11 | 瑞士商諾華公司 | T1dm和胰島炎治療中使用之抗cd40抗體 |
| JP7805788B2 (ja) * | 2019-05-23 | 2026-01-26 | ヤンセン バイオテツク，インコーポレーテツド | Ｉｌ－２３及びｔｎｆアルファに対する抗体の併用療法による炎症性腸疾患の治療方法 |
| IL298389A (en) | 2020-05-21 | 2023-01-01 | Janssen Biotech Inc | Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1079704A (en) | 1912-06-19 | 1913-11-25 | Dallas C Hathaway | Combination tire valve-stem and pressure-gage. |
| EP0043718B1 (en) * | 1980-07-07 | 1984-11-28 | National Research Development Corporation | Improvements in or relating to cell lines |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4816597A (en) * | 1983-10-02 | 1989-03-28 | New Jersey Institute Of Technology | Dental restorative materials based upon blocked isocyanates |
| GB8421551D0 (en) | 1984-08-24 | 1984-09-26 | Ici Plc | Water-soluble dye |
| PT833911E (pt) | 1995-06-07 | 2004-09-30 | Ortho Mcneil Pharm Inc | Anticorpos anti-factor tecidular enxertados com cdr e metodos para a sua utilizacao |
| JP2001507215A (ja) * | 1997-01-16 | 2001-06-05 | サイテル コーポレイション | 組換え糖タンパク質のインビトロでの実用的なシアリル化 |
| DK1071700T3 (da) * | 1998-04-20 | 2010-06-07 | Glycart Biotechnology Ag | Glykosylerings-modifikation af antistoffer til forbedring af antistofafhængig cellulær cytotoksicitet |
| CA2704600C (en) * | 1999-04-09 | 2016-10-25 | Kyowa Kirin Co., Ltd. | A method for producing antibodies with increased adcc activity |
| UA81743C2 (uk) | 2000-08-07 | 2008-02-11 | Центокор, Инк. | МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ |
| US6946292B2 (en) * | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
| EP1360314B1 (en) | 2001-02-15 | 2009-01-14 | Centocor, Inc. | Chemically defined medium for cultured mammalian cells |
| CA2481925A1 (en) * | 2002-04-09 | 2003-10-16 | Kyowa Hakko Kogyo Co., Ltd. | Therapeutic agent for patients having human fc.gamma.riiia |
| BR0309145A (pt) * | 2002-04-09 | 2005-02-01 | Kyowa Hakko Kogyo Kk | Células das quais o genoma é modificado |
| EP1498490A4 (en) * | 2002-04-09 | 2006-11-29 | Kyowa Hakko Kogyo Kk | PROCESS FOR PREPARING ANTIBODY COMPOSITION |
| US7605235B2 (en) * | 2003-05-30 | 2009-10-20 | Centocor, Inc. | Anti-tissue factor antibodies and compositions |
| US20050031615A1 (en) * | 2003-05-30 | 2005-02-10 | Anderson G. Mark | Method of inhibiting tumor growth with anti-tissue factor antibodies |
-
2006
- 2006-08-31 WO PCT/US2006/034382 patent/WO2007028106A2/en not_active Ceased
- 2006-08-31 EP EP06814116A patent/EP1937313A4/en not_active Withdrawn
- 2006-08-31 CA CA002621236A patent/CA2621236A1/en not_active Abandoned
- 2006-08-31 BR BRPI0616600-8A patent/BRPI0616600A2/pt not_active Application Discontinuation
- 2006-08-31 JP JP2008529350A patent/JP2009508476A/ja active Pending
- 2006-08-31 MX MX2008003054A patent/MX2008003054A/es not_active Application Discontinuation
- 2006-08-31 US US12/065,178 patent/US20090214528A1/en not_active Abandoned
- 2006-08-31 KR KR1020087007406A patent/KR20080048505A/ko not_active Ceased
- 2006-08-31 AU AU2006287224A patent/AU2006287224A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009508476A5 (https=) | ||
| CN107217042B (zh) | 一种生产无岩藻糖基化蛋白的基因工程细胞系及其建立方法 | |
| CN106687128B (zh) | 用于治疗代谢病症的组合物和方法 | |
| TWI264467B (en) | Human anti-CD40 antibodies and methods of making and using same | |
| CA3097704A1 (en) | Anti-ror antibody constructs | |
| BR112020026862A2 (pt) | antagonistas antitumorais de reguladores de pontos de verificação imunológica | |
| CA3002602C (en) | Single-chain cd27-receptor agonist proteins | |
| JP2008537874A5 (https=) | ||
| TW200415241A (en) | Fc fusion proteins of human erythropoietin with high biological activities | |
| JP2011506476A5 (https=) | ||
| CA3002588C (en) | Single-chain cd137-receptor agonist proteins | |
| CN111601821B (zh) | 具有对FcRn的亲和力提高以及对至少一个Fc片段受体的亲和力提高的Fc片段的变体 | |
| JPH01502669A (ja) | 精製された血小板由来の成長因子及びその精製方法 | |
| CN105820248A (zh) | 一种新型抗egfr单克隆抗体的制备方法及应用 | |
| JP2018533948A (ja) | 一本鎖ｌｉｇｈｔ受容体アゴニストタンパク質 | |
| CN104974262B (zh) | 重组双功能融合蛋白及其制法和用途 | |
| EP2966085A1 (en) | Antibody IgG1 with a modified heavy chain constant region | |
| CN114829385A (zh) | 包含il-7变体的双功能分子 | |
| CN119907811A (zh) | 针对cd28的多功能分子 | |
| CA3003511A1 (en) | Single-chain tl1a receptor agonist proteins | |
| TW201945392A (zh) | Gcgr抗體及其與glp-1的融合蛋白質，以及其藥物組合物和應用 | |
| TW201825524A (zh) | 新型抗-pcsk9抗體 | |
| CN107460221A (zh) | 一种降低抗pd‑l1抗体中蛋白聚合物的细胞培养方法 | |
| KR20150108841A (ko) | 순환하는 생물활성 가용성 tnf의 선택적 감소를 위한 조성물 및 tnf-매개 질환의 치료 방법 | |
| CN103044554B (zh) | 重组二聚化人尿胰蛋白酶抑制剂、其制备方法及其应用 |